January 22, 2024
LOS ANGELES -- Calibre Scientific is pleased to announce the acquisition of RUWAG Handels AG (“RUWAG” or the “Company”), a provider of diagnostics and life sciences products and services, selling to hospitals, private labs, universities and pharmaceutical companies in Switzerland. This strategic acquisition highlights Calibre Scientific's dedication to broadening its range of products and services [...]
Leadership Update: Welcoming Nick Keher as CFO; Tim Cowper takes COO role
January 22, 2024
Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore” or the “Group”), the company delivering a new generation of nanopore-based molecular sensing technology, today announces the expansion of the leadership team to support the business in its next phase of growth. Following a comprehensive search process, Nick Keher has been appointed as Chief Financial Officer (“CFO”) [...]
X Series for Raman Spectroscopy
January 19, 2024
Morrisville, NC – Wasatch Photonics is excited to announce its new flagship line of compact Raman spectrometers and systems. The WP Raman X series is the most powerful, comprehensive compact Raman product line ever created, with superior sensitivity and flexibility to serve the needs of researchers and OEM instrument developers alike. The X series product family includes modular [...]
STEMCELL Technologies Announces Acquisition of Propagenix Inc.
January 19, 2024
VANCOUVER, British Columbia -- STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. “The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada's biotechnology industry,” said Dr. Allen [...]
January 18, 2024
Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing CARLSBAD, Calif. -- To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software, a first-of-its-kind automation solution designed to [...]
January 18, 2024
COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the ICPMS-2040/2050 series of inductively coupled plasma mass spectrometers that feature a proprietary advanced mini-torch system, a redesigned collision/reaction cell and a high-performance quadrupole mass filter with enhanced resolution. The ICPMS-2040/2050 series is ideal for analyzing the concentration of inorganic elements in solution samples in a wide range [...]
University of Bristol stem cell spinout secures £7.6m seed funding
January 18, 2024
CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round. The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies. Stem cells unlock a range of treatment possibilities that have not previously been available to [...]
AcouSort extends collaboration with leading cell therapy company into a third project phase
January 18, 2024
AcouSort’s collaboration with the global life science company has reached yet another significant milestone with the signing of a Statement of Work (SoW) describing Phase 3 in the ongoing collaboration. The new assignment will generate revenues of at least SEK 485,000 in 2024. The collaboration, which began in 2022, aims to demonstrate how AcouSort’s AcouWash [...]
January 18, 2024
BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company’s protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a [...]
January 18, 2024
PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that the newly established Queensland Spatial Biology Centre (QSBC), located in Brisbane, Australia, is using the PhenoCycler-Fusion spatial biology platform as the core technology to revolutionize the way cancer and [...]

